作者: Riccardo Casadei , Francesco Monari , Salvatore Buscemi , Marco Laterza , Claudio Ricci
DOI: 10.1007/S13304-010-0005-Z
关键词: Surgery 、 Perioperative 、 Pancreatitis 、 Adenocarcinoma 、 Pancreatic cancer 、 Medicine 、 Gastroenterology 、 Neuroendocrine tumors 、 Pancreatic disease 、 Pancreaticoduodenectomy 、 Pancreatectomy 、 Internal medicine
摘要: The aims of this study were to identify the indications perform a total pancreatectomy and evaluate outcome quality life patient who underwent operation. A retrospective analysis prospective database, regarding all patients from January 2006 June 2009, was carried out. Perioperative data analyzed in two different groups: ductal adenocarcinoma (group 1) non-ductal 2). Twenty (16.9%) pancreatectomies out 118 pancreatic resections performed. Seven (35.0%) affected by remaining 13 (65.0%) diseases 2) [8 (61.5%) intraductal mucinous neoplasms, 2 (15.4%) well-differentiated neuroendocrine carcinomas, metastases renal cell cancer and, finally, 1 (7.7%) chronic pancreatitis]. Eleven (55%) primary elective pancreatectomy; nine (45%) had completion previous pancreaticoduodenectomy. Primary significantly more frequent group than 1. Early long-term postoperative results good without significant difference between groups except for disease-free survival that better 2. follow-up examinations showed control apancreatic diabetes exocrine insufficiency differences groups. In conclusion, currently, is standardized safe procedure allows early late results. Its are increasing because diagnose disease involved whole gland as well neoplasm, tumors cancer.